A new trading day began on Friday, with Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock price up 5.85% from the previous day of trading, before settling in for the closing price of $3.93. VNDA’s price has ranged from $3.81 to $6.75 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -1.78%. Meanwhile, its annual earnings per share averaged -352.53%. With a float of $54.97 million, this company’s outstanding shares have now reached $58.93 million.
Let’s determine the extent of company efficiency that accounts for 368 employees. In terms of profitability, gross margin is 69.5%, operating margin of -35.98%, and the pretax margin is -27.63%.
Vanda Pharmaceuticals Inc (VNDA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vanda Pharmaceuticals Inc is 6.73%, while institutional ownership is 75.86%. The most recent insider transaction that took place on Mar 06 ’25, was worth 50,150. In this transaction President and CEO of this company bought 10,000 shares at a rate of $5.01, taking the stock ownership to the 2,295,731 shares. Before that another transaction happened on Mar 05 ’25, when Company’s President and CEO bought 10,000 for $5.02, making the entire transaction worth $50,200. This insider now owns 2,285,731 shares in total.
Vanda Pharmaceuticals Inc (VNDA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -352.53% per share during the next fiscal year.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators
Here are Vanda Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.76, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.39 in one year’s time.
Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)
Looking closely at Vanda Pharmaceuticals Inc (NASDAQ: VNDA), its last 5-days average volume was 0.7 million, which is a jump from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 22.18%. Additionally, its Average True Range was 0.20.
During the past 100 days, Vanda Pharmaceuticals Inc’s (VNDA) raw stochastic average was set at 25.41%, which indicates a significant decrease from 42.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.94% in the past 14 days, which was higher than the 40.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.47, while its 200-day Moving Average is $4.74. However, in the short run, Vanda Pharmaceuticals Inc’s stock first resistance to watch stands at $4.30. Second resistance stands at $4.45. The third major resistance level sits at $4.65. If the price goes on to break the first support level at $3.95, it is likely to go to the next support level at $3.75. Should the price break the second support level, the third support level stands at $3.60.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Key Stats
With a market capitalization of 245.17 million, the company has a total of 58,934K Shares Outstanding. Currently, annual sales are 198,770 K while annual income is -18,900 K. The company’s previous quarter sales were 50,040 K while its latest quarter income was -29,490 K.
